Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2003
08/19/2003US6608029 Reducing gastric motility or delaying gastric emptying in mammal by administering therapeutically effective amount of amylin or amylin agonist, such as pramlintide or pramlintide acetate
08/19/2003US6607893 Measuring diacylglycerol acetyltransferase activity; obtain enzmatic substrate, expose to microsomes, terminate reaction, monitor triglyceride generation
08/19/2003US6607749 Non-fermentable methyl cellulose, lipase inhibitor and edible calcium phosphate salt; fecal incontinence, obesity
08/19/2003CA2299972C Thyromimetic antiobesity agents
08/19/2003CA2066532C Pharmaceutical compositions
08/14/2003WO2003067221A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066859A2 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003WO2003066813A2 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE
08/14/2003WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003WO2003066806A2 Therapeutic use of aziridino compounds
08/14/2003WO2003066672A1 Peptides
08/14/2003WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency
08/14/2003WO2003066647A2 Synthesis of inositolphosphate glycan molecules: treatment of cell proliferation disorders and metabolic disorders characterized by insulin resistance
08/14/2003WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003WO2003066632A1 Sulphonyl compounds with 5 -ht6 receptor affinity
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003066629A2 Heteroaryl compounds useful as inhibitors of gsk-3
08/14/2003WO2003066621A1 Piperidine derivatives and their use as antagonists of tachykinins
08/14/2003WO2003066620A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003WO2003066618A1 Cytoprotective benzofuran derivatives
08/14/2003WO2003066612A1 Novel polymorphic forms of bicyclic antidiabetic agents: process for their preparation and pharmaceutical compositions containing them
08/14/2003WO2003066608A1 Catechol bioisosteres
08/14/2003WO2003066604A2 Novel aryl- and heteroarylpiperazines
08/14/2003WO2003066599A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
08/14/2003WO2003066597A2 Guanidino compounds
08/14/2003WO2003066596A1 Pyridineamido derivatives as inhibitors of monoamine oxidase (mao-b)
08/14/2003WO2003066594A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
08/14/2003WO2003066591A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066590A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066587A2 Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melancortin-4 receptor agonists
08/14/2003WO2003066581A1 Urea linker derivatives for use as ppar modulators
08/14/2003WO2003066561A1 Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066086A2 Proteins involved in the regulation of energy homeostatis
08/14/2003WO2003066084A1 Use of glp-1 compound for treatment of critically ill patients
08/14/2003WO2003066080A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization, or both, in humans
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066074A1 Composition based on plant extracts for lowering and retaining blood sugar level
08/14/2003WO2003066055A1 Quinoline derivatives as npy antagonists
08/14/2003WO2003066050A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003WO2003066047A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066043A1 Stimulation of cpt-1 as a means to reduce weight
08/14/2003WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto
08/14/2003WO2003066028A1 Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003065999A2 Proliferated cell lines and uses thereof
08/14/2003WO2003065991A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003WO2003045437A8 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003WO2003031408A3 Tricyclic compounds useful for modulating lxr
08/14/2003WO2003029433A3 Chimeric viral vectors for gene therapy
08/14/2003WO2003013655A3 Carbonic anhydrase inhibitors
08/14/2003WO2003009813A3 Methods of treating neuropilin-mediated diseases
08/14/2003WO2003000202A3 Particles for inhalation having rapid release properties
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002081430A3 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
08/14/2003WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers
08/14/2003WO2002058733B1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002048154A9 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
08/14/2003WO2002043807A3 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002015933A3 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
08/14/2003WO2002011714A3 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003WO2001055198A9 Dermo- and gastro-specific sphingolipid activator
08/14/2003US20030153756 Pyrimido[5,4-e] [1,2,4]triazine-5, 7-diamine compounds as protein tyrosine phosphatase inhibitors
08/14/2003US20030153628 Aldose reductase inhibitors and pharmaceutical compositions
08/14/2003US20030153621 Administering mixtures of 13-hydroxyoctadeca-9Z,11E-dienoic acid (13-HODE) and carriers comprising glycerides or fatty esters as controllers of endothelial growth factors
08/14/2003US20030153613 Hypotensive agents for eye, using an aclurea indole compounds, potassium channel blockers; glaucoma
08/14/2003US20030153609 C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
08/14/2003US20030153606 Antiproliferative agents for treating adipocyte differentiation, cancer, osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease
08/14/2003US20030153605 Enzyme inhibitors of nitric oxide synthase
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153587 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
08/14/2003US20030153576 Such as amino-indazoles for treatment of central nervous system disorders
08/14/2003US20030153569 Novel pyrazole and pyrazoline substituted compounds
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153563 CRF receptor antagonists and methods relating thereto
08/14/2003US20030153559 Treatment of an oxygen and/or energy deficit; a poly(adenosine diphosphate ribose)-polymerase inhibitor; treating autoimmune, neurodegenerative and diseases caused by a toxic effect; viricides
08/14/2003US20030153557 Treating osteoporosis, cardiovascular disorders, restenosis, arteriosclerosis, nephropathies or retinopathies; antitumor and antiinflammatory agents
08/14/2003US20030153553 Quinoline derivatives
08/14/2003US20030153541 Liver X receptor modulator comprising an oxysterol, lipid regulating HMG-CoA reductase inhibitor, fibric acid derivative, niacin, bile-acid sequestrant, probucol, raloxifene, unsaturated omega-3 fatty acid
08/14/2003US20030153536 Compounds and methods of treating transplant rejection
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153513 Preventives or remedies for obesity or fatty liver
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153497 A polypeptides and polynucleotides encoding the polypeptides, for obesity, insulin resistance, type 2 diabetes, cachexia
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030153073 Expansion of T cells in vitro and expanded T cell populations
08/14/2003US20030152973 G-protein coupled receptor org3
08/14/2003US20030152654 Ginkgo biloba composition, method to prepare the same and uses thereof
08/14/2003US20030152651 Herbal composition for angina pectoris, method to prepare same and uses thereof
08/14/2003US20030152648 Solvent extraction, distillation biomass
1 ... 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 ... 1298